Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií

Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. It represents a group of clinically and biologically heterogenous malignancies that can be subclasified into several subtypes according to the presence of recurrent genetic aberrations. The typical genetic aberrations in...

Full description

Bibliographic Details
Main Author: Žaliová, Markéta
Other Authors: Trka, Jan
Format: Doctoral Thesis
Language:Czech
Published: 2010
Online Access:http://www.nusl.cz/ntk/nusl-278015
id ndltd-nusl.cz-oai-invenio.nusl.cz-278015
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-2780152021-02-26T05:19:15Z Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií TEL/AML1, BCR/ABL and TEL/ABL Fusion genes in childhood acute lymphoblastic leukemia Žaliová, Markéta Trka, Jan Machová Poláková, Kateřina Pospíšilová, Dagmar Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. It represents a group of clinically and biologically heterogenous malignancies that can be subclasified into several subtypes according to the presence of recurrent genetic aberrations. The typical genetic aberrations in childhood ALL are chromosomal translocation, that often result in creation of fusion genes encoding either chimeric kinases or chimeric transcription factors. These recurrent genetic aberations are aquired lesions, they are supposed to be the initial hits (that may arise even prenataly) with a causal role in the process of leukemogenesis, which is, however, in the majority of them not yet fully understood. They further represent specific markes used for the detection of leukemic cells and some of them have also prognostic significance and belong among the factors used for risk group stratification in treatment protocols. Risk group stratification and subsequent risk-adapted therapy together with introduction of new therapeutic approaches (intensive chemotherapeutic regimens involving intrathecal application, hematopoetic stem cell transplantation (HSCT), supportive therapy) account for the significant improvement of the treatment outcomes of childhood ALL in the last decades. In addition to genotype, several... 2010 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-278015 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. It represents a group of clinically and biologically heterogenous malignancies that can be subclasified into several subtypes according to the presence of recurrent genetic aberrations. The typical genetic aberrations in childhood ALL are chromosomal translocation, that often result in creation of fusion genes encoding either chimeric kinases or chimeric transcription factors. These recurrent genetic aberations are aquired lesions, they are supposed to be the initial hits (that may arise even prenataly) with a causal role in the process of leukemogenesis, which is, however, in the majority of them not yet fully understood. They further represent specific markes used for the detection of leukemic cells and some of them have also prognostic significance and belong among the factors used for risk group stratification in treatment protocols. Risk group stratification and subsequent risk-adapted therapy together with introduction of new therapeutic approaches (intensive chemotherapeutic regimens involving intrathecal application, hematopoetic stem cell transplantation (HSCT), supportive therapy) account for the significant improvement of the treatment outcomes of childhood ALL in the last decades. In addition to genotype, several...
author2 Trka, Jan
author_facet Trka, Jan
Žaliová, Markéta
author Žaliová, Markéta
spellingShingle Žaliová, Markéta
Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií
author_sort Žaliová, Markéta
title Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií
title_short Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií
title_full Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií
title_fullStr Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií
title_full_unstemmed Fúzní geny TEL/AML1, BCR/ABL a TEL/ABL u dětských akutních lymfoblastických leukemií
title_sort fúzní geny tel/aml1, bcr/abl a tel/abl u dětských akutních lymfoblastických leukemií
publishDate 2010
url http://www.nusl.cz/ntk/nusl-278015
work_keys_str_mv AT zaliovamarketa fuznigenytelaml1bcrablatelabludetskychakutnichlymfoblastickychleukemii
AT zaliovamarketa telaml1bcrablandtelablfusiongenesinchildhoodacutelymphoblasticleukemia
_version_ 1719378831696986112